FRONTIER CAPITAL MANAGEMENT CO LLC United Therapeutics Corporation Transaction History

FRONTIER CAPITAL MANAGEMENT CO LLC portfolio value:

$39.18M
portfolio value

FRONTIER CAPITAL MANAGEMENT CO LLC quarter portfolio value change:

-11.14%
quarter

United Therapeutics Corporation 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -12.01% -25.55K shares -10.93M $209.38 187.13K
Q2 2022 share Increase +18.50% 33.20K shares 17.91M $235.64 212.68K
Q1 2022 share Decrease -8.61% -16.91K shares -10.23M $179.41 179.47K
Q4 2021 share Increase +124.54% 108.92K shares 26.29M $215.18 196.38K
Q3 2021 share Decrease -20.54% -22.61K shares -3.60M $184.58 87.46K
Q2 2021 share Decrease -14.47% -18.63K shares -1.77M $179.41 110.07K
Q1 2021 share Increase +341.89% 99.57K shares 17.10M $167.27 128.70K
Q4 2020 share Decrease -11.12% -3.64K shares 1.11M $151.79 29.12K
Q3 2020 share Decrease -28.44% -13.02K shares -2.23M $101 32.77K
Q2 2020 share Increase +15.59% 6.17K shares 1.78M $121 45.79K
Q1 2020 share Increase 0.00% 39.61K shares 3.75M $94.83 39.61K
Q1 2017 share Decrease -100.00% -139.26K shares -19.97M $135.38 0
Q4 2016 share Increase +121.39% 76.36K shares 12.54M $143.43 139.26K
Q3 2016 share Decrease -8.73% -6.01K shares 128K $118.08 62.90K
Q2 2016 share Increase +79.36% 30.49K shares 3.01M $105.92 68.91K
Q1 2016 share Decrease -20.33% -9.80K shares -3.27M $111.43 38.42K